IRIS
DE SANCTIS, Rita
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.260
AS - Asia 2.517
SA - Sud America 896
EU - Europa 808
AF - Africa 137
Continente sconosciuto - Info sul continente non disponibili 15
OC - Oceania 9
Totale 7.642
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.161
SG - Singapore 1.439
BR - Brasile 753
CN - Cina 409
VN - Vietnam 365
IT - Italia 152
FI - Finlandia 139
IE - Irlanda 113
DE - Germania 84
FR - Francia 69
NG - Nigeria 69
AR - Argentina 60
CA - Canada 60
GB - Regno Unito 53
HK - Hong Kong 52
IN - India 49
TR - Turchia 43
SE - Svezia 34
NL - Olanda 33
MX - Messico 30
BD - Bangladesh 28
RU - Federazione Russa 27
EC - Ecuador 26
IQ - Iraq 24
ZA - Sudafrica 21
ES - Italia 20
ID - Indonesia 18
IL - Israele 16
MA - Marocco 16
BE - Belgio 15
CL - Cile 14
CO - Colombia 13
UA - Ucraina 12
JP - Giappone 11
EU - Europa 10
PY - Paraguay 10
EG - Egitto 9
VE - Venezuela 9
PL - Polonia 8
AU - Australia 7
CZ - Repubblica Ceca 7
PK - Pakistan 7
RO - Romania 7
SA - Arabia Saudita 7
IR - Iran 6
KE - Kenya 5
NP - Nepal 5
PE - Perù 5
UZ - Uzbekistan 5
AZ - Azerbaigian 4
DZ - Algeria 4
GR - Grecia 4
JO - Giordania 4
LT - Lituania 4
PH - Filippine 4
SN - Senegal 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AT - Austria 3
BO - Bolivia 3
BW - Botswana 3
BY - Bielorussia 3
ET - Etiopia 3
HR - Croazia 3
JM - Giamaica 3
KZ - Kazakistan 3
NO - Norvegia 3
OM - Oman 3
UY - Uruguay 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
AM - Armenia 2
CR - Costa Rica 2
MD - Moldavia 2
MK - Macedonia 2
NZ - Nuova Zelanda 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
XK - ???statistics.table.value.countryCode.XK??? 2
AF - Afghanistan, Repubblica islamica di 1
BH - Bahrain 1
CI - Costa d'Avorio 1
DK - Danimarca 1
EE - Estonia 1
GA - Gabon 1
GE - Georgia 1
HN - Honduras 1
IM - Isola di Man 1
JE - Jersey 1
KG - Kirghizistan 1
KR - Corea 1
KW - Kuwait 1
MN - Mongolia 1
MR - Mauritania 1
MY - Malesia 1
NI - Nicaragua 1
PA - Panama 1
PT - Portogallo 1
QA - Qatar 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
Totale 7.641
Salva come PNG Salva come JPEG
Città #
Singapore 613
Wilmington 467
Ashburn 274
Chandler 232
The Dalles 222
San Mateo 172
Shanghai 171
Ann Arbor 166
Dallas 158
San Jose 146
Helsinki 139
Dublin 113
Ho Chi Minh City 113
New York 107
Leawood 101
Hanoi 95
Beijing 94
Boardman 90
Lawrence 85
Princeton 85
São Paulo 71
Benin City 67
Fairfield 56
Paris 53
Hong Kong 49
Woodbridge 44
Toronto 41
Rio de Janeiro 36
Kocaeli 31
Los Angeles 30
Amsterdam 27
London 26
Milan 20
Assago 16
Phoenix 16
Brussels 15
Seattle 15
Orem 14
Curitiba 13
Da Nang 13
Hải Dương 13
Brasília 12
Guayaquil 12
Monmouth Junction 12
Chennai 11
Montreal 11
Buenos Aires 10
Fortaleza 10
Haiphong 10
Johannesburg 10
Munich 10
Recife 10
Tokyo 10
Biên Hòa 9
Brooklyn 9
Mexico City 9
Naples 9
Porto Alegre 9
Santa Clara 9
Baghdad 8
Atlanta 7
Council Bluffs 7
Falkenstein 7
Natal 7
Pune 7
Quito 7
Belo Horizonte 6
Brno 6
Casablanca 6
Dhaka 6
Erbil 6
Hillsboro 6
New Delhi 6
Norwalk 6
Osasco 6
Salvador 6
San Diego 6
Santiago 6
Warsaw 6
Abbiategrasso 5
Asunción 5
Bắc Ninh 5
Cachoeirinha 5
Cairo 5
Campinas 5
Chicago 5
Franca 5
Frankfurt am Main 5
Manaus 5
Nairobi 5
Ninh Bình 5
Ribeirão Preto 5
Sorocaba 5
São Bernardo do Campo 5
Tashkent 5
Thái Bình 5
Uberlândia 5
Amman 4
Araras 4
Baku 4
Totale 4.721
Salva come PNG Salva come JPEG
Nome #
Biological characteristics and long-term outcomes in node-negative breast cancer 118
Palonosetron plus three-day aprepitant and dexamethasone to prevent nausea and vomiting in patients receiving highly emetogenic chemotherapy 118
Superiority of CHOI vs RECIST criteria in evaluating outcome of advanced soft tissue sarcoma (STS) patients treated with sorafenib 104
Treatment of malignant pleural mesothelioma: current status and future directions 103
Survival outcome and prognostic factors after pulmonary metastasectomy in sarcoma patients 102
Perfusion Computed Tomography as prognostic and predictive factor in patients with colorectal cancer liver metastases treated with bevacizumab 102
Palonosetron plus 3-day aprepitant and dexamethasone to prevent nausea and vomiting in patients receiving highly emetogenic chemotherapy 102
A monocentric retrospective analysis of TILs and AR as hints for prognosis definition in TNBC 101
Safety and efficacy of oral combination of vinorelbine and capecitabine in metastatic breast cancer 100
Imatinib mesylate in desmoplastic small round cell tumour 98
Neutrophil to Lymphocyte Ratio (NLR) as predictive factor in patients with metastatic soft tissue sarcoma (STS) treated with trabectedin (T). 96
Safety and efficacy of oral vinorelbine and capecitabine combination for metastatic breast cancer 94
Zoledronic acid (ZA) and treatment of bone metastasis in patients with advanced lung cancer (NSCLC and SCLC). 93
PERFUSION COMPUTED TOMOGRAPHY AS PROGNOSTIC AND PREDICTIVE FACTOR IN PATIENTS WITH COLORECTAL CANCER LIVER METASTASES TREATED WITH BEVACIZUMAB 93
Colorectal cancer liver metastases treated with target therapies: monitoring response with constrat-enhanced ultrasonography (CE-US). 88
Atypical Lipomatous Tumors: Should They be Treated Like Other Sarcoma or Not? Surgical Consideration from a Bi-Institutional Experience 88
48P The relationship among bowel FDG-PET uptake, pathological complete response, and the influence of eating and exercise habits in breast cancer patients undergoing neoadjuvant chemotherapy 87
Carcinoma gastrico metastatico e Docetaxel, Cisplatino, Fluorouracile (DCF) settimanale: tolleranza e risposta 87
Stereotactic body radiation therapy for lung metastases from soft tissue sarcoma. 86
Phase II study: Docetaxel-cisplatin and pro drug tegafur (TPF) as neoadjuvant treatment in advanced patients with head and neck cancer (HNC): Results and correlation between tandem magnesium/creatinine and toxicity 85
Phase I pharmacokinetic and pharmacodynamic study of lapatinib in combination with sorafenib in patients with advanced refractory solid tumors 84
Activity of regorafenib in advanced pretreated soft tissue sarcoma: Results of a single-center phase II study 82
Colorectal cancer liver metastases treated with target therapies: monitoring response with contrast-enhanced ultrasonography (CE-US). 81
Clinical predictors of cardiac toxicity in HER2-positive early breast cancer patients treated with adjuvant s.c. versus i.v. trastuzumab 81
Response to Sunitinib in an Adult Patient With Rhabdoid Renal Cell Carcinoma 80
Early response evaluation of antiangiogenic therapy: use of contrast-enhanced ultrasonography (CE-US) in hepatocellular carcinoma 80
Phase II prospective study with sorafenib in advanced soft tissue sarcomas after anthracycline-based therapy 79
First-line chemotherapy in over-70 patients with colon cancer. 77
Capecitabine in elderly patients with metastatic breast cancer 77
Docetaxel in combination with gemcitabine as second line treatment in patients with platinum resistant advanced NSCLC 76
A Study of Clinical Features and Risk Factors of Self-Referring Emergency Department Headache Patients: A Comparison with Headache Center Outpatients 76
wALT trial (Phase I-II): weekly non-pegylated liposomal anthracycline and taxane combination in first line breast cancer chemotherapy 75
PET/CT radiomics in breast cancer: promising tool for prediction of pathological response to neoadjuvant chemotherapy 74
Vinorelbine in pemetrexed-pretreated patients with malignant pleural mesothelioma 74
Safety and efficacy of bevacizumab with first-line FOLFIRI for metastatic colorectal cancer: single center experience 73
Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial 73
Efficacy and tolerability of a single-day three drugs combination of aprepitant, palonosetron and dexamethasone in patients receiving moderately emetogenic chemotherapy 72
Predictive Factors of Eribulin Activity in Metastatic Breast Cancer Patients 71
Capecitabine in elderly breast cancer patients 71
Dietary chemoprevention of colorectal cancer 70
WALT TRIAL (PHASE III): WEEKLY NON PEGYLATED LIPOSOMAL ANTHRACYCLINE AND TAXANE COMBINATION IN FIRSTLINE BREAST CANCER CHEMOTHERAPY 70
Descripcion de un sistema de realidad virtual dirigido a la promocion de bienestar emocional en pazientes oncologicoa hospidalizados: ensayo fase II OncoHelp 69
Phase I, pharmacokinetics, pharmacodynamic study of lapatinib in combination with sorafenib in patients with advanced refractory solid tumors 68
Prognostic factors and outcome of HER2+ breast cancer with CNS metastases 67
Long-term Follow-up and Post-relapse Outcome of Patients with Localized Retroperitoneal Sarcoma Treated in the Italian Sarcoma Group-Soft Tissue Sarcoma (ISG-STS) Protocol 0303 67
Bevacizumab in combination with FOLFIRI as first-line treatment for metastatic colorectal cancer: outcomes from a single center experience 67
High-risk soft tissue sarcomas treated with perioperative chemotherapy: Improving prognostic classification in a randomised clinical trial 67
Unsupervised versus Supervised Identification of Prognostic Factors in Patients with Localized Retroperitoneal Sarcoma: A Data Clustering and Mahalanobis Distance Approach 66
Never too old to fight breast cancer 66
Short, full-dose adjuvant chemotherapy (CT) in high-risk adult soft tissue sarcomas (STS): long-term follow-up of a randomized clinical trial from the Italian Sarcoma Group and the Spanish Sarcoma Group 66
HER2-positive breast cancer and CNS metastases: Prognostic factors and clinical outcome 65
A pilot analysis of headache disorders in breast cancer patients 65
Clinical Review on the Management of Breast Cancer Visceral Crisis 64
SAFETY AND EFFICACY OF SORAFENIB FOR ADVANCED HEPATOCELLULAR CARCINOMA 64
A Prognostic Model Based on Residual Cancer Burden and Tumor-Infiltrating Lymphocytes on Residual Disease after Neoadjuvant Therapy in HER2+ Breast Cancer 63
A systematic review of systematic reviews and pooled meta-analysis on pharmacological interventions to improve cancer-related fatigue 63
A Propensity Score Matching Study on the Effect of OnabotulinumtoxinA Alone versus Short-Term Psychodynamic Psychotherapy Plus Drug-of-Choice as Preventive Therapy in Chronic Migraine: Effects and Predictive Factors 62
Preoperative chemo-radiation therapy for localised retroperitoneal sarcoma: A phase I-II study from the Italian Sarcoma Group 62
Trabectedin for the treatment of soft tissues sarcomas 61
TNBC universe: A monocentric retrospective analyses of TILs and AR as prognostic markers 61
Role of Surgery in the Multimodal Treatment of Primary and Recurrent Leiomyosarcoma of the Inferior Vena Cava 61
Platinum salts in the treatment of BRCA-associated breast cancer: A true targeted chemotherapy? 60
Primary breast leiomyosarcoma and synchronous homolateral lung cancer: a case report 60
Non-pegylated liposomal doxorubicin plus ifosfamide in metastatic soft tissue sarcoma: results from a phase-II trial 60
Feasibility of preoperative chemotherapy with or without radiation therapy in localized soft tissue sarcomas of limbs and superficial trunk in the Italian sarcoma group/grupo español de investigación en sarcomas randomized clinical trial: Three versus five cycles of full-dose epirubicin plus ifosfamide 60
Opportunities and Challenges of Synthetic Data Generation in Oncology 59
SAFETY AND EFFICACY OF ORAL COMBINATION CHEMOTHERAPY IN METASTATIC BREAST CANCER: VINORELBINE AND CAPECITABINE 59
The therapeutic potential of duloxetine in prostate cancer-related fatigue 59
Juxtaglomerular cell tumor: Multicentric synchronous disease associated with paraneoplastic syndrome 59
Efficacy of trabectedin in advanced soft tissue sarcoma: Beyond lipo- and leiomyosarcoma 59
Trabectedin for the treatment of soft tissue sarcoma 58
Phase I, pharmacokinetic (PK), pharmacodynamic (PD) study of lapatinib (L) in combination with sorafenib (S) in patients with advanced refractory solid tumors 58
Safety, tolerability and early response evaluation of sarafenib in hepatocellular carcinoma in erderly: use of contrast-enhanced ultrasonography (CE-US). 58
Pulmonary sarcomatoid carcinoma presenting both ALK rearrangement and PD-L1 high positivity: A case report on the therapeutic regimen 57
From seaside to bedside: Current evidence and future perspectives in the treatment of breast cancer using marine compounds 55
Primary ovarian insufficiency associated with pazopanib therapy in a breast angiosarcoma patient: A CARE-compliant case report 55
The role of docetaxel in the multimodal treatment of non-small cell lung cancer 54
Never too old to fight breast cancer: A case report 54
Heterogeneity of triple-negative breast cancer: understanding the Daedalian labyrinth and how it could reveal new drug targets 53
Common Misconceptions about Diet and Breast Cancer: An Unclear Issue to Dispel 53
Imatinib mesylate in desmoplastic small round cell tumors 53
Temporal–occipital glioblastoma presenting with Alice in Wonderland Syndrome in a patient with a long-time history of migraine without aura 53
[Integrated treatment of breast cancer: review of our experience] 52
Palonosetron plus three-day aprepitant and dexamethasone schedule to prevent nausea and vomiting in patients receiving highly emetogenic chemotherapy 52
Fulvestrant and trastuzumab in patients with luminal HER2-positive advanced breast cancer (ABC): an Italian real-world experience (HERMIONE 9) 52
Commentary: Improvement in diagnostic-therapeutic care pathways for women with migraine: an Italian Delphi panel 52
Imaging Correlates between Headache and Breast Cancer: An [18F]FDG PET Study 51
The Role of Female Reproductive Hormones in the Association between Migraine and Breast Cancer: An Unanswered Question 50
Insights for the application of TILs and AR in the treatment of TNBC in routine clinical practice 50
Phase I, Pharmacokinetics (PK), Pharmacodynamic (PD) Study of Lapatinib (L) in Combination With Sorafenib (S) in Patients With Advanced Refractory Solid Tumours 49
[The clinical significance of lymph node micrometastases and of concept of sentinel lymph node] 48
Sporadic desmoid tumors of the abdominal wall: the results of surgery 48
Profiling the Spectrum of Headache Disorders on 440 Breast Cancer Patients: Highlights on Clinical and Pathological Mechanisms 47
Nomograms predicting local and distant recurrence and disease-specific mortality for R0/R1 soft tissue sarcomas of the extremities 47
Charting the Course in Sequencing Antibody-Drug Conjugates in Breast Cancer 47
Defining T cell dysfunctionality in breast cancer by single cell analysis: Implications for immunotherapy 46
Oral vinorelbine in elderly or unfit patients with metastatic NSCLC 46
Unveiling the HER2-low phenomenon: exploring immunohistochemistry and gene expression to characterise HR-positive HER2-negative early breast cancer 45
Potential Role of Circulating miRNAs for Breast Cancer Management in the Neoadjuvant Setting: A Road to Pave 45
Re: Carvedilol blocks neural regulation of breast cancer progression in vivo and is associated with reduced breast cancer mortality in patients: Sympathetic nervous system activity on breast cancer: the story of migraine 45
Totale 6.903
Salva come PNG Salva come JPEG
Categoria #
all - tutte 51.115
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.115
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021209 0 0 0 0 0 0 0 0 0 108 4 97
2021/2022445 32 2 15 79 14 7 12 64 44 77 89 10
2022/2023898 182 19 114 58 79 46 4 72 137 97 78 12
2023/2024779 54 63 164 34 30 110 52 32 8 21 67 144
2024/20251.215 27 3 4 11 15 173 51 118 216 276 151 170
2025/20263.419 486 621 236 419 154 150 825 170 216 142 0 0
Totale 7.787